APA (7th ed.) Citation

Shimada, S., Ivanics, T., Kitajima, T., Shamaa, T., Rizzari, M., Collins, K., . . . Nagai, S. (2022). Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct‐acting antiviral therapies. Transplant Infectious Disease, 24(2), 1. https://doi.org/10.1111/tid.13808

Chicago Style (17th ed.) Citation

Shimada, Shingo, et al. "Improvements in Liver Transplant Outcomes in Patients with HCV/HIV Coinfection After the Introduction of Direct‐acting Antiviral Therapies." Transplant Infectious Disease 24, no. 2 (2022): 1. https://doi.org/10.1111/tid.13808.

MLA (9th ed.) Citation

Shimada, Shingo, et al. "Improvements in Liver Transplant Outcomes in Patients with HCV/HIV Coinfection After the Introduction of Direct‐acting Antiviral Therapies." Transplant Infectious Disease, vol. 24, no. 2, 2022, p. 1, https://doi.org/10.1111/tid.13808.